Ten-year patterns in blood product utilization during cardiothoracic surgery with cardiopulmonary bypass in a tertiary hospital

Transfusion

Volumn 54, Issue 1, 2014, Pages 2608-2616

  Vonk, Alexander B A ^a   Meesters, Michael I ^a,b   Van Dijk, Wouter B ^b   Eijsman, Leon ^a   Romijn, Johannes W A ^b   Jansen, Evert K ^a   Loer, Stephan A ^b   Boer, Christa ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; FRESH FROZEN PLASMA; HEMOGLOBIN; PROTAMINE; TRANEXAMIC ACID;

ARTICLE; BLOOD CONSERVATION; BLOOD SALVAGE; BLOOD TRANSFUSION; BODY TEMPERATURE; CARDIOPULMONARY BYPASS; DATA BASE; ERYTHROCYTE TRANSFUSION; FLUID BALANCE; HEART SURGERY; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; OPERATIVE BLOOD LOSS; SINGLE DRUG DOSE; TERTIARY CARE CENTER; THORAX SURGERY; ALGORITHM; BLOOD LOSS, SURGICAL; BLOOD VOLUME; CORONARY ARTERY BYPASS GRAFT; FACTUAL DATABASE; INTRAOPERATIVE PERIOD; PLASMA; PREDICTIVE VALUE; PROFESSIONAL PRACTICE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; THROMBOCYTE TRANSFUSION; UTILIZATION;

ALGORITHMS; BLOOD LOSS, SURGICAL; BLOOD VOLUME; BODY TEMPERATURE; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; DATABASES, FACTUAL; ERYTHROCYTE TRANSFUSION; HEMOGLOBINS; HUMANS; INTRAOPERATIVE PERIOD; OPERATIVE BLOOD SALVAGE; PLASMA; PLATELET TRANSFUSION; PREDICTIVE VALUE OF TESTS; PROFESSIONAL PRACTICE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS;

EID: 84908467094     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12522     Document Type: Article

References (32)

1. Anderson L, Quasim I, Soutar R, et al. An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. Transfus Med 2006; 16: 31-39.
2. Tinegate H, Chattree S, Iqbal A, et al.; Northern Regional Transfusion Committee. Ten-year pattern of red blood cell use in the North of England. Transfusion 2013; 53: 483-489.
3. Brevig J, McDonald J, Zelinka ES, et al. Blood transfusion reduction in cardiac surgery: multidisciplinary approach at a community hospital. Ann Thorac Surg 2009; 87: 532-539.
4. Xydas S, Magovern CJ, Slater JP, et al. Implementation of a comprehensive blood conservation program can reduce blood use in a community cardiac surgery program. J Thorac Cardiovasc Surg 2012; 143: 926-935.
5. Society of Thoracic Surgeons Blood Conservation Guideline Task Force;, Ferraris VA, Brown JR, Despotis GJ, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91: 944-982.
6. Ranucci M, Aronson S, Dietrich W, et al.; European Association of Cardiothoracic Anaesthesiologists. Patient blood management during cardiac surgery: do we have enough evidence for clinical practice? J Thorac Cardiovasc Surg 2011; 142: 1-32.
7. Theusinger OM, Felix C, Spahn DR,. Strategies to reduce the use of blood products: a European perspective. Curr Opin Anaesthesiol 2012; 25: 59-65.
8. Shander A, Van Aken H, Colomina MJ, et al. Patient blood management in Europe. Br J Anaesth 2012; 109: 55-68.
9. Mangano DT,. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002; 347: 1309-1317.
10. Yende S, Wunderink RG,. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med 2001; 29: 2271-2275.
11. Murphy GS, Hessel EA 2nd, Groom RC,. Optimal perfusion during cardiopulmonary bypass: an evidence-based approach. Anesth Analg 2009; 108: 1394-1417.
12. Mahmood S, Bilal H, Zaman M, et al. Is a fully heparin-bonded cardiopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit? Interact Cardiovasc Thorac Surg 2012; 14: 406-414.
13. Navickis RJ, Haynes GR, Wilkes MM,. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials. J Thorac Cardiovasc Surg 2012; 144: 223-230.
14. Hutton B, Joseph L, Fergusson D, et al. Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies. BMJ 2012; 345: e5798.
15. Weber CF, Görlinger K, Meininger D, et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012; 117: 531-547.
16. Vonk AB, Meesters MI, Garnier RP, et al. Intraoperative cell salvage is associated with reduced postoperative blood loss and transfusion requirements in cardiac surgery: a cohort study. Transfusion 2013; 11: 2782-2789.
17. Geißler RG, Franz D, Buddendick H, et al. Retrospective analysis of the blood component utilization in a university hospital of maximum medical care. Transfus Med Hemother 2012; 39: 129-138.
18. Vonk AB, Meesters MI, Schats J, et al. Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery. Interact Cardiovasc Thorac Surg 2011; 12: 135-139.
19. Despotis GJ, Filos KS, Zoys TN, et al. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients. Anesth Analg 1996; 82: 13-21.
20. Karkouti K, O'Farrell R, Yau TM, et al.; Reducing Bleeding in Cardiac Surgery Research Group. Prediction of massive blood transfusion in cardiac surgery. Can J Anaesth 2006; 53: 781-794.
21. Koch CG, Weng YS, Zhou SX, et al.; Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group. Prevalence of risk factors, and not gender per se, determines short- and long-term survival after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2003; 17: 585-593.
22. Al-Alao BS, Parissis H, McGovern E, et al. Gender influence in isolated coronary artery bypass graft surgery: a propensity match score analysis of early outcomes. Gen Thorac Cardiovasc Surg 2012; 60: 417-424.
23. Nozohoor S, Johnsson P, Scicluna S, et al. A case-controlled evaluation of the Medtronic Resting Heart System compared with conventional cardiopulmonary bypass in patients undergoing isolated coronary artery bypass surgery. Interact Cardiovasc Thorac Surg 2012; 14: 599-604.
24. Redlin M, Habazettl H, Boettcher W, et al. Effects of a comprehensive blood-sparing approach using body weight-adjusted miniaturized cardiopulmonary bypass circuits on transfusion requirements in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2012; 144: 493-499.
25. Vretzakis G, Kleitsaki A, Stamoulis K, et al. Intra-operative intravenous fluid restriction reduces perioperative red blood cell transfusion in elective cardiac surgery, especially in transfusion-prone patients: a prospective, randomized controlled trial. J Cardiothorac Surg 2010; 5: 7.
26. Lee JS, Ahn SW, Song JW, et al. Effect of hydroxyethyl starch 130/0.4 on blood loss and coagulation in patients with recent exposure to dual antiplatelet therapy undergoing off-pump coronary artery bypass graft surgery. Circ J 2011; 75: 2397-2402.
27. Tönz M, Mihaljevic T, von Segesser LK, et al. Normothermia versus hypothermia during cardiopulmonary bypass: a randomized, controlled trial. Ann Thorac Surg 1995; 59: 137-143.
28. Ho KM, Tan JA,. Benefits and risks of maintaining normothermia during cardiopulmonary bypass in adult cardiac surgery: a systematic review. Cardiovasc Ther 2011; 29: 260-279.
29. Dunning J, Versteegh M, Fabbri A, et al.; EACTS Audit and Guidelines Committee. Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur J Cardiothorac Surg 2008; 34: 73-92.
30. De Vroege R, van Oeveren W, van Klarenbosch J, et al. The impact of heparin-coated cardiopulmonary bypass circuits on pulmonary function and the release of inflammatory mediators. Anesth Analg 2004; 98: 1586-1594.
31. Maddux FW, Dickinson TA, Rilla D, et al. Institutional variability of intraoperative red blood cell utilization in coronary artery bypass graft surgery. Am J Med Qual 2009; 24: 403-411.
32. Jin R, Zelinka ES, McDonald J, et al.; Providence Health & Services Cardiovascular Disease Study Group. Effect of hospital culture on blood transfusion in cardiac procedures. Ann Thorac Surg 2013; 95: 1269-1274.